CONMED CORPORATION Repayments of Long-Term Debt
CONMED CORPORATION (CNMD) reported Repayments of Long-Term Debt of $8.28 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-07-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2021-07-29
- CONMED CORPORATION repayments of long-term debt for the quarter ending 2021-06-30 was $4.97M, a 50.00% increase year-over-year.
- CONMED CORPORATION repayments of long-term debt for the quarter ending 2021-03-31 was $3.31M, a 0.00% change year-over-year.
- CONMED CORPORATION repayments of long-term debt for the quarter ending 2020-09-30 was $3.31M, a 0.03% increase year-over-year.
- CONMED CORPORATION repayments of long-term debt for the quarter ending 2020-06-30 was $3.31M, a 0.03% decline year-over-year.
- CONMED CORPORATION repayments of long-term debt for fiscal 2019 was $154.31M, a 1075.71% increase from fiscal 2018.
- CONMED CORPORATION repayments of long-term debt for fiscal 2018 was $13.13M, a 50.00% increase from fiscal 2017.
- CONMED CORPORATION repayments of long-term debt for fiscal 2017 was $8.75M, a 0.00% change from fiscal 2016.
- CONMED CORPORATION repayments of long-term debt for fiscal 2016 was $8.75M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2021-06-30 | $4.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $8.28M 10-Q · filed 2021-07-29 | ||
| 2021-03-31 | $3.31M 10-Q · filed 2021-04-29 | |||
| 2020-09-30 | $3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $6.63M derived: sum of 2 quarters · filed 2021-07-29 | $9.94M 10-Q · filed 2020-10-29 | $13.25M derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-06-30 | $3.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $6.63M 10-Q · filed 2021-07-29 | $9.94M derived: sum of 3 quarters · filed 2021-07-29 | $13.25M derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | $3.31M 10-Q · filed 2021-04-29 | $6.63M derived: sum of 2 quarters · filed 2021-04-29 | $9.94M derived: sum of 3 quarters · filed 2021-04-29 | $13.25M derived: sum of 4 quarters · filed 2021-04-29 |
| 2019-12-31 | $3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $6.62M derived: sum of 2 quarters · filed 2020-10-29 | $9.94M derived: sum of 3 quarters · filed 2020-10-29 | $154.31M 10-K · filed 2020-02-24 |
| 2019-09-30 | $3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $6.63M derived: sum of 2 quarters · filed 2020-10-29 | $151.00M 10-Q · filed 2020-10-29 | $154.28M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | $3.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $147.69M 10-Q · filed 2020-07-30 | $150.97M derived: sum of 3 quarters · filed 2020-07-30 | $154.25M derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-03-31 | $144.38M 10-Q · filed 2020-04-30 | $147.66M derived: sum of 2 quarters · filed 2020-04-30 | $150.94M derived: sum of 3 quarters · filed 2020-04-30 | $154.22M derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-12-31 | $3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $6.56M derived: sum of 2 quarters · filed 2020-02-24 | $9.84M derived: sum of 3 quarters · filed 2020-02-24 | $13.13M 10-K · filed 2020-02-24 |
| 2018-09-30 | $3.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $6.56M derived: sum of 2 quarters · filed 2019-10-31 | $9.84M 10-Q · filed 2019-10-31 | $12.03M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $3.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $6.56M 10-Q · filed 2019-08-01 | $8.75M derived: sum of 3 quarters · filed 2020-02-24 | $10.94M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $3.28M 10-Q · filed 2019-04-26 | $5.47M derived: sum of 2 quarters · filed 2020-02-24 | $7.66M derived: sum of 3 quarters · filed 2020-02-24 | $9.84M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $4.38M derived: sum of 2 quarters · filed 2020-02-24 | $6.56M derived: sum of 3 quarters · filed 2020-02-24 | $8.75M 10-K · filed 2020-02-24 |
| 2017-09-30 | $2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $4.38M derived: sum of 2 quarters · filed 2018-11-02 | $6.56M 10-Q · filed 2018-11-02 | $8.75M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $4.38M 10-Q · filed 2018-08-02 | $6.56M derived: sum of 3 quarters · filed 2019-02-25 | $8.75M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $2.19M 10-Q · filed 2018-04-26 | $4.37M derived: sum of 2 quarters · filed 2019-02-25 | $6.56M derived: sum of 3 quarters · filed 2019-02-25 | $8.75M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $4.37M derived: sum of 2 quarters · filed 2019-02-25 | $6.56M derived: sum of 3 quarters · filed 2019-02-25 | $8.75M 10-K · filed 2019-02-25 |
| 2016-09-30 | $2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $4.38M derived: sum of 2 quarters · filed 2017-11-02 | $6.56M 10-Q · filed 2017-11-02 | $6.56M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $4.38M 10-Q · filed 2017-07-27 | $4.38M derived: sum of 3 quarters · filed 2018-02-26 | |
| 2016-03-31 | $2.19M 10-Q · filed 2017-04-27 | $2.19M derived: sum of 2 quarters · filed 2018-02-26 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 10-K · filed 2018-02-26 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-10-28 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |